Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-Risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06733350
What this trial is testing

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Who this might be right for
Localized Prostate CarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
Roswell Park Cancer Institute 600
Early research (Phase 1)Ended earlyNCT02875223
What this trial is testing

A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinNeoplasms
Celgene 75
Not applicableStudy completedNCT03502213
What this trial is testing

Study In Urology Practices Looking At Impact Of OncotypeDX GPS Test On Men Choosing And Remaining On Active Surveillance

Who this might be right for
Prostate Cancer
Genomic Health®, Inc. 489
Not applicableLooking for participantsNCT07130682
What this trial is testing

Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial

Who this might be right for
Prostate Cancer Patients Treated by Radiotherapy
Hong Kong Sanatorium & Hospital 35
Not applicableLooking for participantsNCT07221825
What this trial is testing

Low-Count Quantitative SPECT for Men Treated With Radium-223

Who this might be right for
Prostate CancerCancer of the Prostate
Washington University School of Medicine 38
Large-scale testing (Phase 3)Active Not RecruitingNCT04513717
What this trial is testing

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Who this might be right for
Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8
NRG Oncology 2,753
Not applicableUnknownNCT02040610
What this trial is testing

Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Provision Center for Proton Therapy 235
Post-approval studies (Phase 4)Study completedNCT00363311
What this trial is testing

Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men

Who this might be right for
Neoplasms, Prostate
GlaxoSmithKline 302
Testing effectiveness (Phase 2)UnknownNCT02643511
What this trial is testing

Hemiablative Focal Brachytherapy Pilot Study

Who this might be right for
Prostate Cancer
St George Hospital, Australia 20
Large-scale testing (Phase 3)UnknownNCT02258087
What this trial is testing

HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.

Who this might be right for
Adenocarcinoma of Prostate
National Institute of Oncology, Hungary 50
Testing effectiveness (Phase 2)Study completedNCT02353832
What this trial is testing

Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal Spacer

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center 44
Large-scale testing (Phase 3)UnknownNCT00295802
What this trial is testing

Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer

Who this might be right for
Prostate Cancer
EDAP TMS S.A. 141
Not applicableStudy completedNCT01192438
What this trial is testing

Laser Based Focal Ablation of Low Grade Prostate Cancer

Who this might be right for
Low Grade Prostate Cancer
University of Chicago 9
Not applicableUnknownNCT02225262
What this trial is testing

A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors

Who this might be right for
Prostate CancerCancer of the ProstateProstate Neoplasm
Community Cancer Center, Normal, Illinois 100
Not applicableStudy completedNCT02600156
What this trial is testing

Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors

Who this might be right for
Prostate CancerProstate AdenocarcinomaStage I Prostate Cancer AJCC v8+2 more
Mayo Clinic 7
Not applicableStudy completedNCT05800483
What this trial is testing

Improving Decision-Making for Low Health Literate Prostate CA Patients

Who this might be right for
Prostate Cancer
Northwell Health 327
Not applicableActive Not RecruitingNCT03426748
What this trial is testing

LDR vs. HDR Brachytherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 140
Not applicableActive Not RecruitingNCT02339701
What this trial is testing

Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 68
Not applicableLooking for participantsNCT05438563
What this trial is testing

MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer

Who this might be right for
Prostate CarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8
Mayo Clinic 100
Testing effectiveness (Phase 2)Ended earlyNCT01928485
What this trial is testing

Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer

Who this might be right for
Stage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate Cancer
Sanjay Gupta PhD 6
Next Page